26 January 2021 News Diurnal licensing deal for paediatric treatment in China Mills & Reeve has advised longstanding client Diurnal Group on an exclusive licensing transaction for the commercialisation of its product Alkindi® in China. Bookmark this page 2 min read
5 October 2020 News IQ Capital participated in investment rounds totalling over £235m in first ten months of 2020 Mills & Reeve has advised long-standing client IQ Capital on a series of investments including investments under the Government backed Future Fund. Bookmark this page 5 min read